Tapewire

Nasdaq · USD

CYTK

CYTOKINETICS INC

Export transactions ↓
Tapewire entity
3528
SEC CIK
0001061983
Parsed reports
875

Last 12 months

Inside the activity.

0 purchase rows · 83 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202509
Jan 202603
Feb 202602
Mar 2026017
Apr 202608
May 202609
Jun 202608
Jul 202609
Aug 202604
Sep 202608
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 27, 2023 Filed Dec 27, 2023 21:11 UTC SaleCommon Stock 5,000 $73.60 $368,000.00
Disclosure

SEC source: 0001127602-23-030485 · form4.xml · nonDerivative · entry 2

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,653

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023.

Read SEC document
December 27, 2023 Filed Dec 27, 2023 21:11 UTC Exercise / conversionCommon Stock 5,000 $4.44 $22,200.00
Disclosure

SEC source: 0001127602-23-030485 · form4.xml · nonDerivative · entry 1

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,653

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023.

Read SEC document
December 18, 2023 Filed Dec 19, 2023 21:13 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-23-030013 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 168,494

Underlying: Common Stock · 12,500 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
December 18, 2023 Filed Dec 19, 2023 21:13 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $36.95 $461,875.00
Disclosure

SEC source: 0001127602-23-030013 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,797

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
December 18, 2023 Filed Dec 19, 2023 21:13 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $6.67 $83,375.00
Disclosure

SEC source: 0001127602-23-030013 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 454,297

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
December 18, 2023 Filed Dec 19, 2023 21:12 UTC Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 13,020 $0.00 Strike: $6.72 $0.00
Disclosure

SEC source: 0001127602-23-030007 · form4.xml · derivative · entry 4

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,020 shares

Expires 2024-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.

F2 · kind: Sell-to-cover transaction. Dr. Henderson acquired a net 10,562 shares of common stock, which he continues to hold.

Read SEC document
December 18, 2023 Filed Dec 19, 2023 21:12 UTC SaleCommon Stock 2,458 $36.34 $89,323.72
Disclosure

SEC source: 0001127602-23-030007 · form4.xml · nonDerivative · entry 3

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,380

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.

F2 · kind: Sell-to-cover transaction. Dr. Henderson acquired a net 10,562 shares of common stock, which he continues to hold.

Read SEC document
December 18, 2023 Filed Dec 19, 2023 21:12 UTC Exercise / conversionCommon Stock 13,020 $6.72 $87,494.40
Disclosure

SEC source: 0001127602-23-030007 · form4.xml · nonDerivative · entry 2

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.

F2 · kind: Sell-to-cover transaction. Dr. Henderson acquired a net 10,562 shares of common stock, which he continues to hold.

Read SEC document
November 30, 2023 Filed Dec 1, 2023 21:15 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-23-028595 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 180,994

Underlying: Common Stock · 12,500 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2023 Filed Dec 1, 2023 21:15 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $32.99 $412,375.00
Disclosure

SEC source: 0001127602-23-028595 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,417

Read SEC document
November 30, 2023 Filed Dec 1, 2023 21:15 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $6.67 $83,375.00
Disclosure

SEC source: 0001127602-23-028595 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 453,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 15, 2023 22:22 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-23-027443 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 193,494

Underlying: Common Stock · 12,500 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 15, 2023 22:22 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $34.57 $432,125.00
Disclosure

SEC source: 0001127602-23-027443 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,417

Read SEC document
November 15, 2023 Filed Nov 15, 2023 22:22 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $6.67 $83,375.00
Disclosure

SEC source: 0001127602-23-027443 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 453,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 09, 2023 Filed Nov 9, 2023 21:35 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 2,500 $35.40 $88,500.00
Disclosure

SEC source: 0001127602-23-027106 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,664

Read SEC document
October 30, 2023 Filed Oct 30, 2023 20:02 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-23-026356 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 205,994

Underlying: Common Stock · 12,500 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 30, 2023 Filed Oct 30, 2023 20:02 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $32.17 $402,125.00
Disclosure

SEC source: 0001127602-23-026356 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,417

Read SEC document
October 30, 2023 Filed Oct 30, 2023 20:02 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $6.67 $83,375.00
Disclosure

SEC source: 0001127602-23-026356 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 453,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 16, 2023 Filed Oct 16, 2023 21:57 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-23-025923 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 218,494

Underlying: Common Stock · 12,500 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 16, 2023 Filed Oct 16, 2023 21:57 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $33.70 $421,250.00
Disclosure

SEC source: 0001127602-23-025923 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,417

Read SEC document
October 16, 2023 Filed Oct 16, 2023 21:57 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $6.67 $83,375.00
Disclosure

SEC source: 0001127602-23-025923 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 453,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 12, 2023 Filed Oct 12, 2023 22:39 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 2,500 $35.89 $89,725.00
Disclosure

SEC source: 0001127602-23-025821 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 153,164

Read SEC document
October 06, 2023 Filed Oct 6, 2023 20:52 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-23-025680 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 230,994

Underlying: Common Stock · 12,500 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 06, 2023 Filed Oct 6, 2023 20:52 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $30.00 $375,000.00
Disclosure

SEC source: 0001127602-23-025680 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,417

Read SEC document
October 06, 2023 Filed Oct 6, 2023 20:52 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $6.67 $83,375.00
Disclosure

SEC source: 0001127602-23-025680 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 453,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 02, 2023 Filed Oct 3, 2023 20:21 UTC GrantCommon Stock 448 $27.88 $12,490.24
Disclosure

SEC source: 0001127602-23-025197 · form4.xml · nonDerivative · entry 1

Harrington Robert Arthur · CIK 0001923988 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,373

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $27.88, representing the closing stock price of the Issuer's common stock on October 2, 2023.

Read SEC document
October 02, 2023 Filed Oct 3, 2023 20:18 UTC GrantCommon Stock 762 $27.88 $21,244.56
Disclosure

SEC source: 0001127602-23-025181 · form4.xml · nonDerivative · entry 1

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,818

F1 · shares: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $27.88, representing the closing stock price of the Issuer's common stock on October 2, 2023.

Read SEC document
October 02, 2023 Filed Oct 3, 2023 20:17 UTC GrantCommon Stock 448 $27.88 $12,490.24
Disclosure

SEC source: 0001127602-23-025179 · form4.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,169

F1 · shares: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $27.88, representing the Issuer's closing stock price on October 2, 2023.

Read SEC document
October 02, 2023 Filed Oct 3, 2023 20:16 UTC GrantCommon Stock 448 $27.88 $12,490.24
Disclosure

SEC source: 0001127602-23-025174 · form4.xml · nonDerivative · entry 1

SMITH SANDFORD D · CIK 0001243004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,653

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $27.88, representing the Issuer's closing stock price on October 2, 2023.

Read SEC document
October 02, 2023 Filed Oct 3, 2023 20:15 UTC GrantCommon Stock 448 $27.88 $12,490.24
Disclosure

SEC source: 0001127602-23-025166 · form4.xml · nonDerivative · entry 1

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,653

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $27.88, representing the Issuer's closing stock price on October 2, 2023.

Read SEC document
October 02, 2023 Filed Oct 3, 2023 20:13 UTC GrantCommon Stock 224 $27.88 $6,245.12
Disclosure

SEC source: 0001127602-23-025160 · form4.xml · nonDerivative · entry 1

Wysenski Nancy · CIK 0001294596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,082

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $27.88, representing the Issuer's closing stock price on October 2, 2023.

Read SEC document
September 14, 2023 Filed Sep 14, 2023 20:09 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 2,500 $34.86 $87,150.00
Disclosure

SEC source: 0001127602-23-024158 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 155,664

Read SEC document
September 13, 2023 Filed Sep 13, 2023 20:09 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-23-024067 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 243,494

Underlying: Common Stock · 12,500 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 13, 2023 Filed Sep 13, 2023 20:09 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $34.90 $436,206.25
Disclosure

SEC source: 0001127602-23-024067 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,417

Read SEC document
September 13, 2023 Filed Sep 13, 2023 20:09 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $6.67 $83,375.00
Disclosure

SEC source: 0001127602-23-024067 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 453,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 25, 2023 Filed Aug 28, 2023 22:45 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001127602-23-023304 · form4.xml · derivative · entry 7

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 25, 2023 Filed Aug 28, 2023 22:45 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-23-023304 · form4.xml · derivative · entry 6

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 255,994

Underlying: Common Stock · 2,500 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 25, 2023 Filed Aug 28, 2023 22:45 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $33.99 $424,875.00
Disclosure

SEC source: 0001127602-23-023304 · form4.xml · nonDerivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,417

Read SEC document
August 25, 2023 Filed Aug 28, 2023 22:45 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 10,000 $7.96 $79,600.00
Disclosure

SEC source: 0001127602-23-023304 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 453,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 25, 2023 Filed Aug 28, 2023 22:45 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 2,500 $6.67 $16,675.00
Disclosure

SEC source: 0001127602-23-023304 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 443,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 21, 2023 Filed Aug 21, 2023 20:01 UTC Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 6,020 $0.00 Strike: $6.72 $0.00
Disclosure

SEC source: 0001127602-23-023012 · form4.xml · derivative · entry 3

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,020 shares

Expires 2024-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 21, 2023 Filed Aug 21, 2023 20:01 UTC SaleCommon Stock 6,020 $32.02 $192,760.40
Disclosure

SEC source: 0001127602-23-023012 · form4.xml · nonDerivative · entry 2

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,205

Read SEC document
August 21, 2023 Filed Aug 21, 2023 20:01 UTC Exercise / conversionCommon Stock 6,020 $6.72 $40,454.40
Disclosure

SEC source: 0001127602-23-023012 · form4.xml · nonDerivative · entry 1

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 11, 2023 Filed Aug 11, 2023 20:18 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative 792 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001127602-23-022368 · form4.xml · derivative · entry 11

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 792 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 11, 2023 Filed Aug 11, 2023 20:18 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative 11,708 $0.00 Strike: $9.65 $0.00
Disclosure

SEC source: 0001127602-23-022368 · form4.xml · derivative · entry 10

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,708 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 11, 2023 Filed Aug 11, 2023 20:18 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 792 $32.37 $25,634.74
Disclosure

SEC source: 0001127602-23-022368 · form4.xml · nonDerivative · entry 8

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,417

F4 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
August 11, 2023 Filed Aug 11, 2023 20:18 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 792 $7.96 $6,304.32
Disclosure

SEC source: 0001127602-23-022368 · form4.xml · nonDerivative · entry 7

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 442,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
August 11, 2023 Filed Aug 11, 2023 20:18 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 11,708 $32.37 $378,954.01
Disclosure

SEC source: 0001127602-23-022368 · form4.xml · nonDerivative · entry 6

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,417

F4 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
August 11, 2023 Filed Aug 11, 2023 20:18 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 11,708 $9.65 $112,982.20
Disclosure

SEC source: 0001127602-23-022368 · form4.xml · nonDerivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 453,125

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
August 10, 2023 Filed Aug 10, 2023 20:14 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 2,500 $31.70 $79,250.00
Disclosure

SEC source: 0001127602-23-022288 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 158,164

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.